Stock comparison

RGCvsVTRS

Regencell Bioscience Holdings LtdvsViatris Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

RGC

Regencell Bioscience Holdings Ltd

$28.31

+70.54%

Pharmaceuticals$11.9BNASDAQ

VTRS

Viatris Inc

$14.75

+26.61%

Pharmaceuticals$15.6BNASDAQ

60-day price, rebased to 100

RGC -12.33% · VTRS +13.72%

Round-by-round

RGC 1·VTRS 2· 3ties

Tie

Valuation upside

— vs +97.70% to DCF fair value

EdgeRGC

Balance-sheet strength

Altman Z 32636.93 vs 0.89

Tie

Fundamental quality

Piotroski 4.00 vs 4.00 (of 9)

Tie

Growth + margins

Rule-of-40 — vs 10.00

EdgeVTRS

60-day momentum

-12.33% vs +13.72% price return

EdgeVTRS

Market-cap liquidity

$11.9B vs $15.6B

Verdict

Across6categories,VTRStakes the edge with2wins to1 (and 3 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onRGCorVTRS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.